INDP 014
Alternative Names: INDP-014Latest Information Update: 06 Sep 2023
At a glance
- Originator Indaptus Therapeutics
- Class Anti-infectives; Bacteria
- Mechanism of Action Immunomodulators; Toll-like receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Infections
Most Recent Events
- 11 Jul 2023 Early research in Infections in USA (IV), prior to July 2023 (Indaptus Therapeutics pipeline, July 2023)